GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NIOX Group PLC (LSE:NIOX) » Definitions » EV-to-FCF

NIOX Group (LSE:NIOX) EV-to-FCF : 23.63 (As of Jun. 21, 2024)


View and export this data going back to 2014. Start your Free Trial

What is NIOX Group EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, NIOX Group's Enterprise Value is £267.01 Mil. NIOX Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was £11.30 Mil. Therefore, NIOX Group's EV-to-FCF for today is 23.63.

The historical rank and industry rank for NIOX Group's EV-to-FCF or its related term are showing as below:

LSE:NIOX' s EV-to-FCF Range Over the Past 10 Years
Min: -10.59   Med: -2.17   Max: 153.66
Current: 23.7

During the past 13 years, the highest EV-to-FCF of NIOX Group was 153.66. The lowest was -10.59. And the median was -2.17.

LSE:NIOX's EV-to-FCF is ranked better than
53.78% of 357 companies
in the Medical Devices & Instruments industry
Industry Median: 26.27 vs LSE:NIOX: 23.70

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-21), NIOX Group's stock price is £0.674. NIOX Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was £0.024. Therefore, NIOX Group's PE Ratio for today is 28.08.


NIOX Group EV-to-FCF Historical Data

The historical data trend for NIOX Group's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NIOX Group EV-to-FCF Chart

NIOX Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.41 -4.36 132.16 20.42 23.29

NIOX Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 132.16 - 20.42 - 23.29

Competitive Comparison of NIOX Group's EV-to-FCF

For the Medical Devices subindustry, NIOX Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NIOX Group's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NIOX Group's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where NIOX Group's EV-to-FCF falls into.



NIOX Group EV-to-FCF Calculation

NIOX Group's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=267.007/11.3
=23.63

NIOX Group's current Enterprise Value is £267.01 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. NIOX Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was £11.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NIOX Group  (LSE:NIOX) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

NIOX Group's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.674/0.024
=28.08

NIOX Group's share price for today is £0.674.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. NIOX Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was £0.024.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


NIOX Group EV-to-FCF Related Terms

Thank you for viewing the detailed overview of NIOX Group's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


NIOX Group (LSE:NIOX) Business Description

Traded in Other Exchanges
Address
Edmund Halley Road, Hayakawa Building, The Oxford Science Park, Oxford, GBR, OX4 4GB
NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, the United States, the United Kingdom, and the Rest of the world.

NIOX Group (LSE:NIOX) Headlines

No Headlines